ADIPOQ and Hyperglycemia: Inhibits hyperglycemia in KKAy mice, decreases plasma and hepatic triglyceride (TG) levels, increases plasma adiponectin concentrations, participates in the stimulation of peroxisome proliferator-activated receptor (PPAR) β pathways and fatty acid β-oxidation in vivo.